TG and hematocrit: HT patients had a significant reduction in absolute serum Tg antibodies (TgAb), but not thyroperoxidase antibodies (TPOAb), after 12 weeks of anatabine supplementation, confirming an immunological effect of anatabine in humans as shown previously in the mouse model of EAT [71].